Journal of Cancer Cervix Eradication

Volume: 2(2), December 2018, Pages: 1-6

Received 4 Sep 2018; Accepted 1 Nov 2018;

Available online 30 December 2018

Abstract

Over the last 80 years, the relative morbidity and mortality of locally advanced invasive cervical cancer has declined in the United States and Europe because of effective screening and treatment of preinvasive lesions2. The American Cancer Society estimates in 2018 that approximately 13,240 new cases of invasive carcinoma of the cervix arise in the United States and about 4,170 deaths will occur per year, in addition to >60,000 cases of carcinoma in situ3.  Adjusting for population growth and aging, the global incidence rate for cervical cancer declined by 1.2% from 2005–20154. But there is no Indian data available. As most of the cases in India present in an advanced stage of disease so main modality of treatment is Concurrent Chemoradiation. Delivering optimum dose to the target and minimising the dose to surrounding normal structure is a real challenge for radiation oncologist. In the era of modern technology this problem is being taken care by advanced and sophisticated machines also computerised dose delivering techniques.

Keyword

Evolution. Radiation. Therapy., Carcinoma Cervix